C57BL/6JCya-Duoxa2em1/Cya
Common Name
Duoxa2-KO
Product ID
S-KO-11922
Backgroud
C57BL/6JCya
Strain ID
KOCMP-66811-Duoxa2-B6J-VA
When using this mouse strain in a publication, please cite “Duoxa2-KO Mouse (Catalog S-KO-11922) were purchased from Cyagen.”
Product Type
Age
Genotype
Sex
Quantity
Basic Information
Strain Name
Duoxa2-KO
Strain ID
KOCMP-66811-Duoxa2-B6J-VA
Gene Name
Product ID
S-KO-11922
Gene Alias
9030623N16Rik, Nip2
Background
C57BL/6JCya
NCBI ID
Modification
Conventional knockout
Chromosome
Chr 2
Phenotype
Datasheet
Application
--
Strain Description
Ensembl Number
ENSMUST00000028656
NCBI RefSeq
NM_025777
Target Region
Exon 2~3
Size of Effective Region
~1.1 kb
Overview of Gene Research
DUOXA2, also known as dual oxidase maturation factor 2, is a crucial factor for the maturation and activation of dual oxidase DUOX2, a member of the NADPH oxidase family. It aids DUOX2 in correctly migrating from the endoplasmic reticulum to the plasma membrane, and together they form a stable complex promoting hydrogen peroxide (H2O2) generation in thyroid hormone synthesis [2].
Genetic alterations in DUOXA2 lead to defective function of DUOX2 protein, causing inherited congenital hypothyroidism (CH) [2]. In a cohort of 377 CH cases, DUOXA2 was prominent in thyroid dysgenesis (TD) cases (18.75%) [1]. A study reported a nonsense DUOXA2 mutation (p.Tyr138*) in a girl with congenital hypothyroidism and her apparently unaffected brother, and expression experiments in HEK293 cells confirmed it as a loss-of-function mutation, suggesting a broader phenotypic spectrum of DUOXA2 mutations [3]. In a cross-sectional study of borderline CH cases, 6 out of 52 patients (12%) harbored likely pathogenic mutations in DUOXA2, including novel gene variants [4].
In conclusion, DUOXA2 is essential for thyroid hormone synthesis through its role in DUOX2 activation. Mutations in DUOXA2 are associated with congenital hypothyroidism, including in TD and borderline CH cases. The study of DUOXA2 mutations in such disease conditions helps in understanding the genetic basis of congenital hypothyroidism and potentially improving diagnosis and treatment strategies.
References:
1. Wang, Fengqi, Zang, Yucui, Li, Miaomiao, Wang, Fang, Liu, Shiguo. 2020. DUOX2 and DUOXA2 Variants Confer Susceptibility to Thyroid Dysgenesis and Gland-in-situ With Congenital Hypothyroidism. In Frontiers in endocrinology, 11, 237. doi:10.3389/fendo.2020.00237. https://pubmed.ncbi.nlm.nih.gov/32425884/
2. Du, Jiani, Yang, Yanling, Wei, Ding, Cheng, Chen, Zhai, Xiaoyan. 2024. The role of DUOXA2 in the clinical diagnosis of paediatric congenital hypothyroidism. In Annals of medicine, 57, 2440121. doi:10.1080/07853890.2024.2440121. https://pubmed.ncbi.nlm.nih.gov/39673194/
3. Sugisawa, Chiho, Higuchi, Shinji, Takagi, Masaki, Hasegawa, Tomonobu, Narumi, Satoshi. 2017. Homozygous DUOXA2 mutation (p.Tyr138*) in a girl with congenital hypothyroidism and her apparently unaffected brother: Case report and review of the literature. In Endocrine journal, 64, 807-812. doi:10.1507/endocrj.EJ16-0564. https://pubmed.ncbi.nlm.nih.gov/28626131/
4. Peters, Catherine, Nicholas, Adeline K, Schoenmakers, Erik, Fugazzola, Laura, Schoenmakers, Nadia. . DUOX2/DUOXA2 Mutations Frequently Cause Congenital Hypothyroidism that Evades Detection on Newborn Screening in the United Kingdom. In Thyroid : official journal of the American Thyroid Association, 29, 790-801. doi:10.1089/thy.2018.0587. https://pubmed.ncbi.nlm.nih.gov/31044655/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
